Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac allograft vasculopathy: current concepts

H O Ventura1, M R Mehra, F W Smart

  • 1Ochsner Medical Institutions, New Orleans, LA 70121.

American Heart Journal
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing immunosuppression in heart transplantation: "one step forward, two steps back.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

The emergence of a dynamic intervention paradigm in heart failure.

Ochsner journal·2011
Same author

The 500 heart transplant.

Ochsner journal·2011
Same author

Utility of heart biopsy in transplant patients.

Ochsner journal·2011
Same author

Albert Ochsner, MD: Chicago Surgeon and Mentor to Alton Ochsner.

Ochsner journal·2011
Same author

Obesity and the "obesity paradox" in cardiovascular diseases.

Clinical pharmacology and therapeutics·2011
Same journal

International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.

American heart journal·2026
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
See all related articles

Cardiac allograft vasculopathy, a major cause of late death in heart transplant recipients, is a distinct form of atherosclerosis. Early detection and understanding its unique characteristics are crucial for managing this post-transplant complication.

Area of Science:

  • Cardiology
  • Transplant Medicine
  • Immunology

Background:

  • Cardiac allograft vasculopathy (CAV) is the primary cause of late mortality in heart transplant recipients, affecting 15-20% of patients.
  • CAV is characterized by concentric, diffuse intimal hyperplasia, intact internal elastic lamina, rare calcification, and rapid progression, distinguishing it from traditional atherosclerosis.

Purpose of the Study:

  • To summarize the key features, potential causes, diagnostic methods, and treatment outcomes of cardiac allograft vasculopathy.

Main Methods:

  • Review of existing literature on cardiac allograft vasculopathy.
  • Comparison of diagnostic modalities including intravascular ultrasound, coronary angioscopy, and coronary angiography.
  • Evaluation of current therapeutic strategies, primarily retransplantation.

Related Experiment Videos

Main Results:

  • CAV presents differently from traditional atherosclerosis, involving myointimal proliferation potentially driven by immunologic and non-immunologic endothelial damage.
  • Intravascular ultrasound and coronary angioscopy demonstrate higher sensitivity in diagnosing CAV compared to coronary angiography.
  • Retransplantation, while the only definitive therapy, offers only moderate success rates.

Conclusions:

  • Cardiac allograft vasculopathy is a significant challenge in heart transplantation, necessitating further research into its pathogenesis and improved therapeutic interventions.
  • Accurate and sensitive diagnostic tools are essential for timely management of CAV.
  • The limited efficacy of current treatments highlights the need for novel approaches to prevent or treat CAV.